Table 2.

Clinical Outcome at 3 Months

TAVI, transcatheter aortic valve implantation; SAVR, surgical aortic valve replacement; OMT, optimal medical therapy.

Major adverse cardiovascular and cerebrovascular events, a composite of all-cause mortality, myocardial infarction, major stroke and re-hospitalization.

^*Due to aortic stenosis or complications of TAVI or SAVR.

^†,‡In case of results with a p-value <0.05 from the 3-group comparison, three additional pairwise comparisons were performed between each two groups. Groups with a p-value <0.05 from the pairwise comparisons were labeled with ^†,‡representing the groups with the higher and lower rates, respectively; i.e. The comparison between ^†(higher) vs. ^‡(lower) was significant.

^§For complete atrioventricular block, the comparison between SAVR vs. OMT was only marginally significant with p=0.059.